Feature Video
Multiple Myeloma Defined
Dr Noopur Raje opens this program with a brief discussion on the basics of multiple myeloma. She describes what the disease is, highlights key risk factors, and explains how she helps educate her patients on their diagnosis. Cynthia Harrington discusses her role as a nurse practitioner when working with multiple myeloma patients and why a team-based approach between healthcare providers and the patient is important.
Expert Talks Treating Newly Diagnosed Patients With Myeloma
BY Angelica Welch
The way that newly diagnosed patients with multiple myeloma is treated has changed significantly over recent years, especially as new drugs moved into the treatment realm for the disease, says Shaji K. Kumar, M.D.
Improving Treatment for Elderly Patients With Myeloma
BY Gina Columbus
Several questions still remain regarding the treatment strategies for elderly patients with multiple myeloma, many of whom may have other comorbidities or trouble tolerating therapies.
Individualized Treatment Needed for Relapsed, Refractory Multiple Myeloma
BY Wayne Kuznar
Patients with relapsed/refractory multiple myeloma should be given individualized treatment approaches guided by the biology of their disease, frailty of the patient and other comorbidities, said Natalie S. Callander, M.D., who presented on the topic at the NCCN 12th Annual Congress: Hematologic Malignancies in San Francisco, California.
Myeloma Specialists Share Their Treatment Strategies
BY Christina Loguidice
Experts in multiple myeloma share the newest information on the goals of therapy in symptomatic disease, testing for minimal residual disease, the role of transplantation, and the use of maintenance therapy.
Acupuncture Reduces Symptom Burden in Patients With Multiple Myeloma
BY Katie Kosko
Acupuncture is a powerful resource that has been around for thousands of years. The traditional Chinese medicine is effective in treating chronic pain and headaches, and is now being used by many patients with cancer as a complementary therapy alongside medicinal treatment.
Survival Rates Increase Faster Than Costs in Myeloma
BY Brielle Urciuoli
For people with multiple myeloma, dollars spent on treatment are being stretched farther than they used to be, a recent study shows.
Patient Advocacy Contributes to Progress in Multiple Myeloma Treatment
BY Mindy Waizer
David S. Siegel, M.D., Ph.D., chief of the division of Multiple Myeloma at the John Theurer Cancer Center, attributes some of the progress in myeloma treatment to patients and how they advocate for themselves.  
FDA Provides an Update on Halted Myeloma Trials
BY Jason M. Broderick
The Food and Drug Administration (FDA) recently released a statement providing data from the two phase 3 trials testing Keytruda (pembrolizumab) in patients with multiple myeloma. The trials were placed on clinical holds by the FDA in July, after concerns arose regarding the drug’s safety in this group of patients.
XPO1 Inhibitor Offers Novel Mechanism for Treating Penta-Refractory Myeloma
BY Ariela Katz
Selinexor (KPT-330), a small-molecule inhibitor with a novel mechanism of action, is being investigated in patients with multiple myeloma (MM) who have become refractory to the many new options that have been introduced in recent years for patients with the malignancy.
Expert Talks Advancements in Multiple Myeloma Treatment
BY Gina Columbus
Peter Voorhees, M.D., discusses the advancements in multiple myeloma treatment, as well as where he hopes the field will go in coming years. 
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Myeloma CURE discussion group.
Search Cancer Drugs & Terms
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
Expert-reviewed information summary about the treatment of plasma cell neoplasms (including multiple myeloma).
Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
Expert-reviewed information summary about the treatment of plasma cell neoplasms (including multiple myeloma).
//For side ad protocol